Journal of Microscopy and Ultrastructure · 2013 · 11 citations · 37 references
MedicineOncologyPathologyEndocrine OncologyMetastasisTumor PathologyEndocrine Tumor PathologyThyroid CancerThyroid CytologyThyroid DisordersThyroid EndocrinologyClinicopathological CorrelationDisease-free Survival AnalysisDisease-free Survival AssessmentPapillary Thyroid Carcinoma PathologyParaffin EmbeddingStatistical TestingThyroid Cancer PathologyThyroid Tumor Histopathology
Background: Osteopontin (OPN) is expressed in various malignancies and may play an important role in tumorigenesis, tumour invasion, and metastasis in various malignancies including thyroid cancers. The objective of this study was to investigate the relationship between OPN immunoexpression and clinicopathological characteristics in thyroid lesions.Material and methods: Paraffin blocks belonging to 160 patients with thyroid neoplasms were retrieved from the archive of the Department of Pathology at King Abdulaziz University, and King Faisal Specialist Hospital, Jeddah, Saudi Arabia. Immunohistochemistry was performed using anti-OPN antibody. Statistical tests were used to determine the relation of OPN immunoexpression to clinicopathological characteristics and survival.Results: Immunostaining results showed that OPN was localised in the cytoplasm and nucleus with higher cytoplasmic expression. Cytoplasmic and nuclear OPN was higher in thyroid cancer than other lesions. Microcarcinoma variant of papillary thyroid carcinoma showed a lower OPN cytoplasmic level than other variants. OPN cytoplasmic expression was not associated with most of the clinicopathological parameters tests. However, OPN cytoplasmic overexpression was associated poor survival outcome (p < 0.001).Conclusion: Upregulation of cytoplasmic OPN was associated with poor survival outcome and was an independent predictor of margin involvement and recurrence. Nuclear OPN expression was lower than cytoplasmic and was associated with extrathyroid extension of thyroid cancer. OPN plays a role in thyroid carcinoma and incoming research has to be focused on the mechanistic association with invasion and metastasis.
37
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Samy Ashkar, Georg F. Weber, Marie Sanchirico et al. · Science · 2000 · 1.1K citations
Life Sciences, Immunology, Pathology +17
Osteopontin as a Potential Diagnostic Biomarker for Ovarian Cancer
Jae‐Hoon Kim · JAMA · 2002 · 507 citations · Full text
Medicine, Gynecology, Oncology +15